We then sought to explore whether this GBA mutation-linked sphingolipids profile (characterized by an elevated glucosylceramide fraction and a reduced sphingomyelin fraction) is useful for stratifying common, idiopathic PD patients without known GBA mutations. The gene discussed is GBA1; the disease is Parkinson disease.